BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has committed to acquiring €2.1 million worth of PCR tests to support the ongoing Bundibugyo Ebola outbreak. These open-platform diagnostic tools are intended to enhance detection capabilities and bolster laboratory infrastructure amidst the emergency. The procurement was facilitated with assistance from the European Health and Digital Executive Agency. Shipment of supplies will commence in August, supplementing health authorities’ efforts as case numbers escalate in the Democratic Republic of the Congo.
The PCR tests will be transported to the World Health Organization’s Logistics Hub for Global Health Emergencies in Dubai. WHO will coordinate their distribution to the zones involved in Ebola containment. PCR testing is crucial for confirming infections because laboratories can analyze numerous samples with high precision. The equipment is compatible with existing laboratory setups, enabling faster diagnosis, which helps health teams identify infected individuals, organize suitable treatment and isolation, and carry out contact tracing around confirmed cases.
This recent procurement complements a separate agreement by the European Commission that provided €2.5 million for rapid molecular point-of-care testing kits and instruments. Those supplies aim to assist the Africa Centres for Disease Control and Prevention. Collectively, these two agreements raise the European Commission’s recent diagnostic support total to €4.6 million. These measures are part of a broader European initiative to respond to the Bundibugyo virus outbreak, which is exerting increasing pressure on healthcare systems in affected regions of Central and East Africa.
Testing capacities expand amid escalating outbreak
As of August 12, WHO reported 4,665 confirmed cases and 2,184 deaths in the Democratic Republic of the Congo. The outbreak has affected 54 health zones across six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized this as the largest Ebola epidemic ever recorded in the country. The agency also highlighted that transmission remains vigorous, with interconnected geographic clusters facilitating ongoing spread within the affected regions.
On August 14, WHO maintained its highest national risk level for the Democratic Republic of the Congo. It also classified the risk for neighboring nations as high, while considering other countries’ risk as low. After a second meeting of its International Health Regulations Emergency Committee, WHO issued updated temporary guidelines on August 24. These recommendations encompass surveillance, case detection, infection prevention, clinical treatment, community engagement, and measures related to domestic movement and mass gatherings.
European support now totals €493 million for emergency responses
The European Commission announced that it has mobilized €493 million to fund emergency aid, vaccines, treatments, and health security measures across the Great Lakes and Uganda regions. European health authorities have also contributed to surveillance efforts, laboratory work, and preparedness initiatives during the outbreak. The European Centre for Disease Prevention and Control continues to assess the risk to Europe as very low, citing the need for direct contact with infectious bodily fluids and the low likelihood of sustained transmission within Europe.
The Bundibugyo outbreak remains designated as a public health emergency of international concern, a status declared by WHO on May 17. Unlike the more common Zaire ebolavirus, the Bundibugyo virus currently has no approved vaccine or specific treatment. WHO continues emphasizing the importance of surveillance, rapid diagnosis, isolation, clinical care, infection control, and contact tracing. The latest laboratory procurement by the European Commission enhances these efforts, while WHO and Africa CDC coordinate health activities alongside national authorities in affected and nearby countries.